M428-0723 Screening compound: N~1~-(sec-butyl)-2-({6-[3-methyl-5,6-dihydrocyclopenta[c]pyrazol-2(4H)-yl]-3-pyridazinyl}sulfanyl)acetamide

M428-0723 Screening compound: N~1~-(sec-butyl)-2-({6-[3-methyl-5,6-dihydrocyclopenta[c]pyrazol-2(4H)-yl]-3-pyridazinyl}sulfanyl)acetamide
M428-0723 Screening compound: N~1~-(sec-butyl)-2-({6-[3-methyl-5,6-dihydrocyclopenta[c]pyrazol-2(4H)-yl]-3-pyridazinyl}sulfanyl)acetamide alternative view

Chemical Structure Depiction of ChemDiv screening compound M428-0723
N~1~-(sec-butyl)-2-({6-[3-methyl-5,6-dihydrocyclopenta[c]pyrazol-2(4H)-yl]-3-pyridazinyl}sulfanyl)acetamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

M428-0723

Molecular Formula

C17H23N5OS (C17 H23 N5 OS)

Compound Name

N~1~-(sec-butyl)-2-({6-[3-methyl-5,6-dihydrocyclopenta[c]pyrazol-2(4H)-yl]-3-pyridazinyl}sulfanyl)acetamide

IUPAC name

N-(butan-2-yl)-2-[(6-{3-methyl-2H4H5H6H-cyclopenta[c]pyrazol-2-yl}pyridazin-3-yl)sulfanyl]acetamide

SMILES

CCC(C)NC(CSc(cc1)nnc1-n1nc(CCC2)c2c1C)=O

InChI

InChI=1S/C17H23N5OS/c1-4-11(2)18-16(23)10-24-17-9-8-15(19-20-17)22-12(3)13-6-5-7-14(13)21-22/h8-9,11H,4-7,10H2,1-3H3,(H,18,23)

InChI Key

PEWDOEBADNOJNQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27541236

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

345.47

Hydrogen Bond Acceptors Count

6.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

7.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

2.233

Distribution Coefficient, logD

2.232

Water Solubility, LogSw

-2.58

Polar Surface Area

60.347

Acid Dissociation Constant (pKa)

15.94

Base Dissociation Constant (pKb)

4.75

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

52.94

M428-0723 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

Antiviral Library (67538 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Soluble Diversity Library (15920 compounds)

Targeted Diversity Library (40567 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Antiviral
  • Infections
  • Immune system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases

References: we are preparing a list of scientific research reports with M428-0723 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound M428-0723?
Check Price and Availability of M428-0723, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of M428-0723 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for M428-0723
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for M428-0723
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of M428-0723 available by request